发表论文 |
近5年发表通讯作者SCI论文20余篇,部分代表性论文如下:(*通讯作者) 1.Mao L, Zhou Y, Chen L,Hu L, Liu S, Zheng W,Zhao J, Guo M, Chen Chao, He Z,Xu L*. Identification of atypical mitogen-activated protein kinase MAPK4as a novel regulator in acute lung injury. Cell Biosci, 2020.10:121. 2.Zhao X,Yang J,Huang R,Guo M,Zhou Y,Xu L*.Therole ofintermittent fastingin tumor: friend or foe? Cancer Biol Med, 2020. 3.Zhao J,Chu F, Xu H, Mao L,Ding T, Shan S,Li Y, Zheng W, Lei L, Lu J, Guo M, Tao Y, CuiP,Zhou Y, Hu Y, Chen C, Ren T,Xu L*..AnC/EBPα/MicroRNA-7axis negatively controls CD4+T cell activation and functionviaby targeting MAPK4/MK5 pathway. Hepatology, 2020. 4.Zhao J, Zhou Y, Guo M, Yue D, Chen C, Liang G,Xu L*. MicroRNA-7: expression and function in brain physiological and pathological processes. Cell Biosci, 2020.10:77. 5.Yue D, Zhao J, Chen H, Guo M, Chen C, Zhou Y,Xu L*. MiRNA-7, synergizes with RORα, negatively controls the pathology of Brain Tissue Inflammatory. J Neuroinflammation, 2020.17(1):28. 6.Din T, Zhou Y, Long R, Chen C, Zhao J, Cui P, Guo M, Liang G,Xu L*. DUSP8 Phosphatase: Structure, Functions, Expression Regulation and the Role in Human Diseases. Cell Biosci, 2019.9:70. 7.Ding T, Cui P, Zhou Y, Chen C, Zhao J, Wang H, Guo M, He Z,Xu L*. Antisense oligonucleotides against microRNA-21 inhibited the growth and metastasis of colorectal carcinoma cells via DUSP8 pathway. Mol Ther Neucli ACIDS. 2018.13:244-255. 8.Jia L, Lu J, Zhou Y, Tao Y, Xu H, Zheng W, Zhao J, Liang G,Xu L*. Tolerogenic dendritic cells induced the enrichment of CD4+Foxp3+ regulatory T cells via TGF-β in mesenteric lymph nodes of murine LPS-induced tolerance model. Clin Immunol. 2018;197:118-129. 9.Wang H, Liu S, Jia L, Chu F, Zhou Y, He Z, Guo M, Chen C,Xu L*. Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy. Cancer Cell Inter, 2018, 18:101. 10.Chen C, Yue D, Lei L, Wang H, Jia L, Zhou Y, Liu S, Ding T, Guo M,Xu L*. Promoter-operating Targeted expression of Gene therapy in cancer: current stage and prospect.Mol Ther Neucli ACIDS. 2018, 11(6):508-514. 11.Zheng W, Zhou Y, Lu J, Xu H, Lei L, Chen C, Zhao J,Xu L*. Theprognostic value of miR-126 expression in non-small-cell lung cancer: A meta-analysis.Canc Cell Int, 2017,17:71. ** 12.Lei L, Chen C, Zhao J, Wang H, Guo M, Zhou Y, Luo J, Zhang J,Xu L*.Targeted expression of miR-7 operated by TTF-1 promoter inhibited the growth of human lung cancer through NDUFA4 pathway.Mol Ther Nucleic Acids, 2017, 6(3):183-197.** 13.Zhao J, Chen C, Guo M, Tao Y, Cui P, Zhou Y, Qin N, Zheng J, Zhang J,Xu L*. MicroRNA-7 deficiency ameliorates the pathologies of Acute Lung Injury through Elevating KLF4.Front Immunol, 2016. 7:389. |